Colorectal Cancer clinical trials
Showing 301–350 of 533 active trials. Describe your situation to see which ones you may be eligible for.
- Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics
- Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)
- Guardant Shield Colorectal Cancer Screening
- Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cancer Patients
- Strategies for Optimizing a Mailed FIT Program in Appalachia
- Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities
- An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response
- Feasibility of a Multi-Channel Intervention to Promote Colorectal Cancer Screening Among American Indians in Oklahoma
- Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps
- Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.
- Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- The Ohio State University (OSU) SCREEN Community Program
- NYC Cancer Outreach Network in Neighborhoods for Equity and Community Translation
- [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
- The Vanguard Study: Testing a New Way to Screen for Cancer
- Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
- Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)
- Intravital Microscopy in Human Solid Tumors
- 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
- A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
- Actinium 225 Labeled Anti-CEA Antibody (Ac225-DOTA-M5A) for the Treatment of CEA Producing Advanced or Metastatic Cancers
- A Study of a Urine Test to Detect Colorectal Cancer
- A Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients With Abnormal Fecal Immunochemical Test Results, PROACT Trial
- Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer
- Smart Symptom Tracking ALEX Application for Tracking and Monitoring Gastrointestinal Health, Smart Horizons Pilot Trial
- Early-Onset Colorectal Cancer Patients Too Young for Screening
- Collection of Samples From the United States Population for Optimization and Evaluation of Colorectal Cancer (CRC) Plasma Circulating Free-DNA (cfDNA) Marker Panel Performance
- Splicing-based Predictive Learning for Individual Chemotherapy Evaluation in Colorectal Cancer
- cfDNA 5mC/5hmC Biomarkers to Predict Chemotherapy Response in Metastatic Colorectal Cancer
- Development of a cfDNA 5mC/5hmC-based Biomarker Panel to Predict Targeted Therapy Efficacy in mCRC
- Exosome-derived Extrahepatic Metastasis Detection By Liquid Biopsy In Colorectal Cancer Liver Metastases
- Liquid Biopsy for Early Detection of Colorectal Cancer Using Circular RNA
- ColoSense Post-Approval Study
- Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC)
- FITting Non-invasive Tests in Lynch Syndrome Surveillance
- Precision-MRD: Prospective Observational Study of Biomarker-directed Systemic Therapy for Colorectal Cancer Patients With Minimal Residual Disease
- Shield Post-Approval Study Protocol
- Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test
- CRC Screening in Unscreened Individuals 45-54
- Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed Resection
- Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection
- Early Detection of Advanced Adenomas and Colorectal Cancer
- Early Onset Colorectal Cancer Detection
- Stage II/III Colorectal Cancer Recurrence
- Surveillance Colonoscopy in Older Adults: The SurvOlderAdults Study
- Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
- Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients
- A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
- Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
- Living Donor Liver Transplant for Unresectable Colorectal Liver Metastases
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.